Loading ...

IR870/DOX-loaded TAT peptide-PEG77-b-PHEP25 nanoparticles

Based on

1 Articles
2017 Most recent source

Composition

1

TAT peptide-poly(ethylene glycol)-block-poly(2-hexyloxy-2-oxo-1,3,2-dioxaphospholane)

TAT peptide-PEG77-b-PHEP25 TAT-PEG-b-PHEP
Type Complex Compound
Formula
Role raw materials
2

near-infrared dye IR780 iodide

IR-780 iodide NIR dye IR780 IR780 iodide IR-780 IR780
Type Single Compound
Formula C36H44ClIN2
Role loaded material
3

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
colloidal stability

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
female mouse

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
Product

IR870/DOX-loaded TAT peptide-PEG77-b-PHEP25 nanoparticles

Size: not specified

Medium: phosphate buffer solution

Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • adriblastin
  • TAT peptide-poly(ethylene glycol)-block-poly(2-hexyloxy-2-oxo-1,3,2-dioxaphospholane)
  • near-infrared dye IR780 iodide
  1. ZFQUtPfgZAe754vUpcCwE1ovGg7tgfgdSt3
  2. q73f83IO
Product

IR870/DOX-loaded TAT peptide-PEG77-b-PHEP25 nanoparticles

Diameter: 80 nm

Medium/Support: none

Method 3

Type: Physical formation
Source:
Starting materials
Product

IR870/DOX-loaded TAT peptide-PEG77-b-PHEP25 nanoparticles

Size: not specified

Medium: phosphate buffer solution

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial